Neurodegenerative Diseases

Latest News

Assessing Diagnostic Accuracy of Alzheimer Disease, Dementia by Primary Care Providers

Researchers sought to identify health care system factors that contribute to missed or delayed diagnosis of dementia by primary care providers.

First Diagnostic Agent Approved to Image Tau Pathology for Alzheimer Disease

The FDA has approved Tauvid for PET imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary tangles.

Tobacco Smoking May Lower Risk for Parkinson Disease While Increasing the Risk of Other Illnesses

A study found a causally protective effect of tobacco smoking on the risk of Parkinson disease.

FDA Grants Fast Track Status to Arimoclomol for ALS

The FDA has granted Fast Track designation to arimoclomol (Orphazyme A/S) for the treatment of amyotrophic lateral sclerosis.

Sublingual Apomorphine Hydrochloride Approved for Off Episodes in Parkinson Disease

This sublingual film formulation of apomorphine was designed for use as a fast-acting, on-demand treatment for all types of motor off episodes.

Patients With Neuromyelitis Optica at Increased Risk for Fracture

Given the limited data is available on bone health of patients with NMOSD-AQP4, researchers aimed to investigate their risk for fracture and bone loss.

Most Patients With Parkinson Disease Report “Burdensome” Time Between Symptom Onset and Diagnosis

A study finds that a majority of patients with Parkinson disease report difficulties in achieving early detection of their disease.

Anti-TNF Agents May Lower Alzheimer Disease Risk for Patients With Psoriasis, Rheumatoid Arthritis

A subset of patients at risk for Alzheimer disease because of systemic inflammation may benefit from receiving a tumor necrosis factor blocking agent.

Psoriasis Linked to Inreased Risk for Alzheimer Disease

The risk for AD among patients with psoriasis was significantly increased in psoriasis patients not receiving systemic therapy compared with those receiving systemic therapy.

Reviews Assess Tools to Identify, Diagnose, Treat Alzheimer Dementia

Many cognitive tests can differentiate clinical Alzheimer-type dementia from normal cognition.